Schedule 13G ownership disclosure

BioMarin Pharmaceutical Inc

Common Stock · CUSIP: 09061G101

Event date: 2025-12-31

Filing-level shares
17,560,751
Percent of class
9.1%
  • BlackRock, Inc.

    Shares: 17,560,751 · Class: 9.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-26-000650
Form type
SCHEDULE 13G/A
Filer
BIOMARIN PHARMACEUTICAL INC
CIK
CIK 1048477
Filed
Jan 21, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub